tradingkey.logo
搜索

Myomo Inc

MYO
添加自选
0.910USD
+0.026+2.97%
收盘 05/15, 16:00美东报价延迟15分钟
35.17M总市值
亏损市盈率 TTM

Myomo Inc

0.910
+0.026+2.97%

关于 Myomo Inc 公司

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc简介

公司代码MYO
公司名称Myomo Inc
上市日期Jun 12, 2017
CEOGudonis (Paul R)
员工数量184
证券类型Ordinary Share
年结日Jun 12
公司地址137 Portland Street
城市BOSTON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编02114
电话16179969058
网址https://myomo.com/
公司代码MYO
上市日期Jun 12, 2017
CEOGudonis (Paul R)

Myomo Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.11M
-13.32%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
--
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
358.41K
-21.82%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
--
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
80.99K
-73.62%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.11M
-13.32%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
--
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
358.41K
-21.82%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
--
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
80.99K
-73.62%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025Q3
FY2025Q2
FY2025Q1
业务USD
名称
营收
占比
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%

股东统计

更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Rosalind Advisors, Inc.
9.94%
Horton Capital Management LLC
5.07%
BlackRock Institutional Trust Company, N.A.
3.96%
Vanguard Capital Management, LLC
2.96%
Gudonis (Paul R)
2.88%
其他
75.19%
持股股东
持股股东
占比
Rosalind Advisors, Inc.
9.94%
Horton Capital Management LLC
5.07%
BlackRock Institutional Trust Company, N.A.
3.96%
Vanguard Capital Management, LLC
2.96%
Gudonis (Paul R)
2.88%
其他
75.19%
股东类型
持股股东
占比
Hedge Fund
16.43%
Investment Advisor
12.82%
Investment Advisor/Hedge Fund
7.64%
Individual Investor
6.78%
Research Firm
4.41%
Venture Capital
0.42%
Bank and Trust
0.14%
Pension Fund
0.12%
Family Office
0.03%
其他
51.20%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
185
23.44M
63.19%
-5.84M
2025Q4
169
22.12M
57.56%
-3.94M
2025Q3
153
21.95M
58.07%
-1.84M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Rosalind Advisors, Inc.
3.84M
9.97%
+48.98K
+1.29%
Dec 31, 2025
Horton Capital Management LLC
1.96M
5.09%
+1.96M
--
Dec 24, 2025
BlackRock Institutional Trust Company, N.A.
1.53M
3.97%
+34.56K
+2.31%
Dec 31, 2025
Gudonis (Paul R)
1.26M
3.27%
+11.64K
+0.93%
Jan 12, 2026
Geode Capital Management, L.L.C.
736.97K
1.91%
-67.47K
-8.39%
Dec 31, 2025
Jefferies LLC
704.27K
1.83%
+704.27K
--
Dec 31, 2025
Kirk (Thomas F)
553.86K
1.44%
+72.00K
+14.94%
Mar 13, 2026
Goldman Sachs & Company, Inc.
466.70K
1.21%
-566.87K
-54.85%
Dec 31, 2025
AQR Capital Management, LLC
434.38K
1.13%
+140.43K
+47.77%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
占比0.01%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
Global X Russell 2000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
ProShares UltraPro Russell2000
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI